Medical Genetics & Genomics
Annals of Medicine
In the Medical Genetics & Genomics section of Annals of Medicine we consider for publication the latest advances in:
| Behavioral Genetics | Biochemical Genetics | Clinical Genetics | Cytogenetics |
| Dysmorphology | Environmental or Lifestyle Factors | Epigenomics | Gene Therapy |
| Genetic Association Studies | Genetic Counselling | Genetic Epidemiology | Genetic Models (in vitro, in vivo and in silico) |
| Genomics | Genomic Editing | Metagenomics | Molecular Genetics |
| Pharmacogenetics | Population Genetics | Phenome-wide Association Studies | Precision Medicine |
| Proteomics | Transcriptomics |
Annals of Medicine
Q1 Rank
Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840
MEDLINE® Indexed
CiteScore 5.70
Meet the Section Editor
Martin Qiuyu Zhu, MD, PhD, Center for Genomic Medicine, Massachusetts General Hospital, Boston, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, USA; Broad Institute of MIT and Harvard, Cambridge, USA
Dr. Zhu is an Internist and Instructor with a research focus on novel genetic risk factors for coronary artery disease. Dr. Zhu completed clinical training in Cardiology in China. He obtained his PhD in Physiology at the University of Rochester, USA, investigating the genetic basis of thrombosis and novel regulators of endothelial exocytosis, as well as the application of gene editing in studying vascular disease. Dr. Zhu completed postdoctoral research under Drs. Sekar Kathiresan and Patrick Ellinor at the Massachusetts General Hospital. He was an HHMI “Med-into-Grad” Fellow in Cardiovascular Sciences at the University of Rochester. His research has received fellowship awards by the American Heart Association and funding by the Broad Institute.
Why is Annals of Medicine the Best Publication for Your Research?
Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;
Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;
Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;
Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.
